The popularity of Viagra initially fueled a surge for pharma, nevertheless recent changes present a uncertain scenario for shareholders. Off-patent alternatives are eroding revenue, and continued patent challenges add https://karimznke697794.dailyblogzz.com/41666917/the-blue-pill-and-big-pharma-a-precarious-bet